Professor Sir Andrew Pollard in Conversation with Scott Crawford

We are honoured to welcome Professor Sir Andrew Pollard, Director of the Oxford Vaccine Group and Professor of Paediatric Infection and Immunity in the Department of Paediatrics at the University of Oxford, and an honorary consultant paediatrician at Oxford Children’s Hospital
and Fellow of St Cross College. Recipient of innumerable international distinguished awards, Sir Andrew received a knighthood in the Queen’s Birthday Honours in 2021 for services to Public Health, especially in the pandemic. He was the chief investigator for the clinical trials of the Oxford-AstraZeneca COVID-19 vaccine in 2020, which led to authorisation of the vaccine for use in more than 175 countries with over 2.5 billion doses distributed by the end of 2021.

His research includes the design, development and clinical evaluation of vaccines in UK, Asia, Africa and Latin America, including those for COVID-19, typhoid, meningococcus, Haemophilus influenzae type b, pneumococcus, plague, pertussis, influenza, rabies, coronavirus and Ebola, and leads studies using a human challenge model of paratyphoid and typhoid.

Sir Andrew made the first British ascent of Jaonli (6632m) in 1988 and Chamlang in 1991 (7309m) and was the deputy leader of the successful 1994 British Medical Everest Expedition.

Photo credit: John Cairns Photography

£12 | £10 | £5 (students)